Colgate-Palmolive Company (CL) Q2 2026 Earnings Call Transcript

Colgate-Palmolive Company ( CL ) Q2 2026 Earnings Call July 31, 2026 8:30 AM EDT Company Participants Claire Ross - Executive Vice President of Investor Relations Noel Wallace - Chairman, CEO & President John Faucher - Executive Vice President of M&A and Special Stanley Sutula - Chief Financial Officer Conference Call Participants Dara Mohsenian - Morgan Stanley, Research Division Peter Grom - UBS Investment Bank, Research Division Lauren Lieberman - Barclays Bank PLC, Research Division Robert Ottenstein - Evercore ISI Institutional Equities, Research Division Christopher Carey - Wells Fargo Securities, LLC, Research Division Andrea Teixeira - JPMorgan Chase & Co, Research Division Filippo Falorni - Citigroup Inc., Research Division Kaumil Gajrawala - Jefferies LLC, Research Division Kevin Grundy - BNP Paribas, Research Division Peter Galbo - BofA Securities, Research Division Bonnie Herzog - Goldman Sachs Group, Inc., Research Division Robert Moskow - TD Cowen, Research Division Michael Lavery - Piper Sandler & Co., Research Division Olivia Tong Cheang - Raymond James & Associates, Inc., Research Division Stephen Robert Powers - Deutsche Bank AG, Research Division Edward Lewis - Rothschild & Co Redburn, Research Division Presentation Operator Good morning. Welcome to today's Colgate-Palmolive Second Quarter 2026 Earnings Conference Call. This call is being recorded and is being simulcast live at www.colgatepalmolive.com. Now for opening remarks, I'd like to turn this call over to EVP, Investor Relations, Claire Ross. Claire Ross Executive Vice President of Investor Relations Good morning, and welcome to our second quarter 2026 earnings release conference call. This is Claire Ross, Executive Vice President, Investor Relations. Today's conference call will include forward-looking statements. Actual results could differ materially from these statements. Forward-looking statements inherently involve risks and uncertainties and are made on the basis of our views and assumptions at this time. Please refer to the earnings press release and our most recent filings with the SEC, including our 2025 annual report on Form 10-K and subsequent SEC filings, all available on our website for a discussion